NCT05983965 2025-09-10Study of Tazemetostat in Lymphoid MalignanciesUniversity of Alabama at BirminghamPhase 1 Recruiting30 enrolled
NCT02220842 2020-01-27A Safety and Pharmacology Study of Atezolizumab (MPDL3280A) Administered With Obinutuzumab or Tazemetostat in Participants With Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-cell LymphomaHoffmann-La RochePhase 1 Completed96 enrolled